CAMP
CAMP4 THERAPEUTICS CORPORATION
NASDAQ: CAMP · HEALTHCARE · BIOTECHNOLOGY
$4.01
-6.09% today
Updated 2026-04-29
Market cap
$230.55M
P/E ratio
—
P/S ratio
65.91x
EPS (TTM)
$-2.65
Dividend yield
—
52W range
$1 – $8
Volume
0.2M
CAMP4 THERAPEUTICS CORPORATION (CAMP) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |